According to the endogenous RPL22L1 expressions (Fig. 2A), two stable overexpression GBM cell lines and the control were established (T98G-RPL22L1/Vec and LN229-RPL22L1/Vec, Fig. 2B). The gene discussed is RPL22L1; the disease is glioblastoma.